Microbiological evaluation of glycerolized cadaveric donor skin

Transplantation

Volumn 65, Issue 7, 1998, Pages 966-970

  Van Baare, Jeroen ^a   Ligtvoet, Eric E J ^c   Middelkoop, Esther ^b  

^a Euro Skin Bank   (Netherlands)

^b RED CROSS HOSPITAL   (Netherlands)

^c Laboratory of Public Health Haarlem   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCEROL;

ARTICLE; BACILLUS; BACTERIAL GROWTH; CADAVER DONOR; HUMAN; HUMAN TISSUE; INFECTION RISK; ORGAN PRESERVATION; PRIORITY JOURNAL; SKIN TRANSPLANTATION; STAPHYLOCOCCUS EPIDERMIDIS;

ANTI-BACTERIAL AGENTS; CADAVER; GLYCEROL; HUMANS; ORGAN PRESERVATION; ORGAN PRESERVATION SOLUTIONS; SKIN; TISSUE DONORS;

EID: 0032522380     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199804150-00017     Document Type: Article

References (29)

1. Brown JB, Fryer MP, Ronda UP, Lu M. Post mortem homografts as biological dressings for extensive burns and denuded areas. Ann Surg 1953; 138: 618.
2. Kreis RW, Hoekstra MJ, Mackie DP, Vloemans AFPM, Hermans RP. Historical appraisal of the use of skin allografts in the treatment of extensive full skin thickness burns at the Red Cross Hospital Burns Centre, Beverwijk, The Netherlands. Burns 1992; 18: S19.
3. Rosenquist MD, Cram AE, Kealey G. Short-term preservation at 4°C: skin storage configuration and tissue-to-volume medium ratio. J Burn Care Rehabil 1988; 9: 52.
4. Hira MH, Tajima S, Yamamoto Y. The metabolism of skin grafts stored with excess carbon dioxide. Plast Reconstr Surg 1992; 89: 1122.
5. Titley OG, Cooper M, Thomas A, Hancock K. Stored skin-stored trouble? Br J Plast Surg 1994; 47: 24.
6. Kreis RW, Vloemans AFPM, Hoekstra MJ, Mackie DP, Hermans RP. The use of non-viable glycerol-preserved cadaver skin combined with expanded autografts in the treatment of extensive third-degree burns. J Trauma 1989; 29: 51.
7. Hussmann J, Russell RC, Kucan JO, Hebebrand D, Bradley T, Steinan HU. The use of glycerolized human allografts as temporary (and permanent) cover in adults and children. Burns 1994; 20: S61.
8. Puig LB, Verginelli GV, Belotti G, at al. Homologous dura mater cardiac valve. Preliminary study of 30 cases. J Thorac Cardiovasc Surg 1972; 64: 154.
9. Puig LB, Verginelli G, Kawabe R, et al. Four years experience with dura mater cardiac valves. J Cardiovasc Surg 1977; 18: 247.
10. Ferrans VJ, Milei J, Ishitara T, Storino R. Structural changes in implanted cardiac valvular bioprotheses constructed of glycerol-treated human dura mater. Eur J Cardiothorac Surg 1991; 5: 144.
11. Bishop AJ, Glasby MA, Houlton JE. A morphological assessment of vein allografts preserved in glycerol and used for arterial replacement. J Cardiovasc Surg 1987; 28: 491.
12. Wolff K, Dienemann D. Vessel preservation with glycerol: an experimental study in rats. J Oral Maxillofac Surg 1990; 48: 914.
13. King JH, McTigue JW, Meryman HT. A simple method of preservation of corneas for lamellar keratoplasty. Am J Ophthalmol 1962; 53: 445.
14. Sabates FN, Buesseler JA, Krosney NM, Yamashita T. Experimental and clinical studies of glycerin preserved scleral homografts (a preliminary report). Eye Ear Nose Throat Mon 1967; 46: 1162.
15. Gabrielli MFR, Okamoto T, Marcantonio E, Barbosa CE. Autogenous transplantation of rib cartilage, preserved in glycerol, to the malar process of rats: a histological study. J Nihon Univ Sch Dent 1986; 27: 87.
16. Okamoto T, Gabrielli MAC, de Oliveira OB Jr, Marcantonio E., Gabriella MFR. Autogenous transplantation of rib cartilage preserved in glycerol, after removal of the perichondrium, to the malar process of rats: a histological study (part I). J Nihon Univ Sch Dent 1990; 32: 116.
17. Liao K, Seifter E, Gong G, Yellin EL, Frater RWM. Improved biocompatibility of bovine pericardium using a new method of crosslinking. ASAIO Trans 1991; 37: M175.
18. Billingham RE, Medawar PB. The freezing, drying and storage of mammalian skin. J Exp Biol 1953; 39: 454.
19. Basile ARD. A comparative study of glycerinized and lyophilized porcine skin in dressings for third degree burns. Plast Reconstr Surg 1982; 69: 969.
20. Kreis RW, Vloemans RFPM, Hoekstra MJ, Mackie DP, Hermans RP. The use of nonviable glycerol-preserved cadaver skin combined with widely expanded autografts in the treatment of extensive third degree burns. J Trauma 1989; 29: 51.
21. Richters CD, Hoekstra MJ, van Baare J, du Pont JS, Kamperdijk EWA. Immunogenicity of glycerol-preserved human cadaver skin in vitro. J Burn Care Rehabil 1997; 18.
22. Van Baare J, Buitenwerf J, Hoekstra MJ, du Pont JS. Virucidal effect of glycerol as used in donor skin preservation. Burns 1994; 20: S77.
23. Marshall L, Ghosh MM, Boyce SG, MacNeil S, Freedlander E, Kudeisa G. Effect of glycerol on intracellular virus survival: implications for the clinical use of glycerol-preserved cadaver skin. Burns 1995; 21: 356.
24. Goodman LS, Gilman A. The pharmacological basis of therapeutics, 3rd ed. New York: MacMillan, 1965: 977.
25. De Backere ACJ. Euro Skin Bank: large scale skin-banking in Europe based on glycerol-preservation of donor skin. Burns 1994; 20: S4.
26. Richters CD, Hoekstra MJ, van Baare J, du Pont JS, Kamperdijk EWA. Morphology of glycerol-preserved human cadaver skin. Burns 1996; 22: 113.
27. Pigossi N, Raia A, Lex A, et al. Estudo experimental e clínico sôbre o emprego, como implante, da dura-matér homógena conservada em glicerina à temperatura ambiente. Rev Assoc Med Bras 1971; 17: 263.
28. Monafo WW, Tandon SN, Bradley RE, et al. Bacterial contamination of skin used as a biological dressing: a potential hazard. JAMA 1976; 235: 1248.
29. Cameron PU, Pagnon JC, Reece J, Vardaxis N, Crowe SM. Inactivation of intracellular and extracellular HIV-1 after glycerol treatment at 4°C. Abstract presented at Workshop on Glycerol-Preserved Donor Skin, Amsterdam, October 3, 1996.